A previous study reported that compared with controls, the activation of NLRP3 inflammasome in liver tissues in NASH was enhanced [45], and NLRP3 inflammasome activation promoted the development of NASH toward to fibrosis [46]. Here, NLRP3 is linked to metabolic dysfunction-associated steatohepatitis.